This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GeneWize Expands DNA Customization Into 3 Mega Markets

ORLANDO, Fla., March 28, 2011 /PRNewswire/ -- GeneWize Life Sciences, Inc., a wholly owned subsidiary of GeneLink, Inc. (OTCQB: GNLK), has announced the world's first full-line of skin care products customized to an individual's DNA and the first gene-modulating weight management supplement to complement their revolutionary DNA customized nutritional supplement.  

Starting on March 12, GeneWize distributors were able to provide their customers a DNA personalized skin care system with six nutrient-rich products created just for one's skin genetic needs. Also on March 12, GeneWize distributors added to their product line a weight management supplement. This product modulates genes that affect metabolism, fat absorption and oxidation giving customers an edge in weight management that's not been available until now.

GeneWize President Sharon Tahaney explained: "The disruptive innovation of customizing products to an individual's personal genetics is just emerging, and is expected to have a significant impact on the combined $20 billion U.S. markets of skin care, weight management, and wellness supplements.   The addition of a full line of DNA personalized skin care products to the proven success of DNA nutrition along with a weight management supplement solidifies GeneLink and GeneWize as the consumer genetics early mover setting a new standard in personalized health and beauty. "

GeneLink, through GeneWize, was the first company to market products personalized through the world's hottest breakthrough technology – your DNA. In that short time, GeneWize has experienced over $20M in revenue. Mrs. Tahaney added: "In less than three years of marketing its DNA customized nutrition and skincare products, GeneWize is experiencing more than three times the typical expected customer loyalty among autoship models. GeneWize connects the dots between science and real world application, giving our wellness network a fresh solution to looking, feeling and living their best lives. The loyalty of our customers, the new competitive price range of our line, and the cutting edge science behind our products has given the GeneWize affiliate a true competitive advantage. Now, the extension of our product offerings, and the increasing awareness of the importance of consumer genetics is providing tremendous excitement as we move forward in 2011. We are eager to officially introduce our new lines, presentations and marketing support at our GeneWize annual event in Las Vegas in June."  

About GeneWize Life Sciences, Inc. :

GeneWize is a wholly owned subsidiary of GeneLink Biosciences, Inc. and the first network sales company to focus on providing individually customized nutritional and skin care formulations based on a consumer's personal DNA assessment. The company's mission is to empower individuals to take personal responsibility and control of their health. For more information visit www.genewize.com

About GeneLink Biosciences, Inc.:

GeneLink is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink's patented technologies include proprietary DNA test assessments linked to personalized health, beauty and wellness applications and products. Its DNA assessments provide information that enables the customization of nutritional and skincare products designed and manufactured to fulfill each individual consumer's wellness needs. For more information visit www.genelinkbio.com

This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs